Aeluma's Selloff Could Be Setting Up Its Next Big Move

Aeluma's stock fell after fiscal 2026 earnings showed wider losses and accelerated spending, but the company remains well capitalized with more than $56 million on hand. The company is transitioning toward scalable manufacturing of its patented photonic wafer technology, with CHIPS funding, government contracts, and engineering deals signaling accelerating commercialization. Analysts rate Aeluma a Moderate Buy with a $25 consensus target, and rising institutional buying alongside high short interest could fuel a rebound or short squeeze. Aeluma’s NASDAQ: ALMU stock price is under pressure in 2026 because the market has no appetite for risky, cash-burning startups without real revenue. However, Aeluma is not a run-of-the-mill startup, and a catalyst is in play that investors can capitalize on. The company is in the midst of a major transition, from research, development, and niche production to scalable manufacturing of advanced photonic equipment. Photonics is critical to many advancing technologies, not just AI. It enables faster speeds, more bandwidth, and greater reliability than copper wiring, especially in rugged or high-power applications, including data centers, aerospace, space, industrial, robotics, and quantum computing. Highlights from fiscal 2026 indicate that Aeluma's timeline to commercialization is accelerating. These highlights include intent to claim $30 million in CHIPS funding, $5.3 million in recently awarded government development contracts, an expanded leadership team, and advancing discussions for non-recurring engineering agreements. Non-recurring engineering agreements don’t sound all that interesting, but they can be worth millions in revenue, validate the technology, lead to follow-on orders, and broaden demand. Follow-on orders matter most because they come from engineering design wins, locking this company’s photonic devices into a long-term product cycle. Aeluma Reduces Costs and Improves Performance for Clients Aeluma’s technology is one to watch as it could significantly disrupt the photonic industry. Current standards include “gluing” photonic components onto the silicon wafer substrate. It gets the job done but creates hurdles, including misalignments and signal degradation across the interface. Aeluma’s patented technology “grows” photonic materials directly onto the substrate, creating a two-sided wafer. Aeluma’s process enables larger manufacturing volumes, reduces manufacturing steps, and produces a wafer that can pass through traditional foundry equipment without requiring specialized equipment. This means greater efficiency from the get-go: more wafers at lower cost, with less waste, fewer errors, and greater capacity to transfer optical input to the silicon circuits. Aeluma has what the semiconductor industry needs; what remains is product validation and the capacity to scale. Aeluma Plunges After Earnings Are Released Aeluma did not provide a bullish catalyst in its Q4 fiscal 2026 (FY2026) earnings report, and it was unlikely to. The market wants a contract win and real revenue, which is more likely in Q1 or Q2 of FY2027. Instead, Aeluma announced accelerated spending and wider losses, unpopular in today’s market. Even so, the spend is focused on team expansion, go-to-market efforts, and capacity, which align with the accelerating commercialization timeline. Looking ahead, spending is expected to continue accelerating. The forecast is for approximately $11 million in capital expenditure on top of...